Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gammaitoni

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
Pain Medicine (Malden, Mass.)|August 25, 2015
An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release HydrocodoneSrinivas Nalamachu, Oscar A deLeon-Casasola, Cynthia Y Robinson, et al.
Journal of Patient-Reported Outcomes|October 31, 2021
Translation and cultural validation of the University of Washington Caregiver Stress and Benefit ScalesDagmar Amtmann, Alyssa M Bamer, Rana Salem, et al.
Journal of Opioid Management|November 5, 2015
Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrateCharles Argoff, Paul Arnstein, Steven Stanos, et al.
Journal of Clinical Pharmacology|March 18, 2003
Randomized, double-blind, placebo-controlled comparison of the analgesic efficacy of oxycodone 10 mg/acetaminophen 325 mg versus controlled-release oxycodone 20 mg in postsurgical painArnold R Gammaitoni, Bradley S Galer, Scott Bulloch, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapyValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
The Journal of Pain|September 1, 2006
Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning?Mark P Jensen, Robert H Dworkin, Arnold R Gammaitoni, et al.
The Journal of Pain|March 10, 2010
The assessment of pain quality: an item response theory analysisClare Waterman, Timothy W Victor, Mark P Jensen, et al.
Epilepsy & Behavior : E&B|February 8, 2018
Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver surveyJonathan D Campbell, Melanie D Whittington, Chong H Kim, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 29, 2002
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitorsAntonio Bonati, Paolo Lunghi, Loretta Gammaitoni, et al.
Pain Medicine (Malden, Mass.)|April 23, 2004
Palliative pharmaceutical care: a randomized, prospective study of telephone-based prescription and medication counseling services for treating chronic painA R Gammaitoni, R M Gallagher, M Welz, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
Pain Medicine (Malden, Mass.)|August 25, 2015
An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release HydrocodoneSrinivas Nalamachu, Oscar A deLeon-Casasola, Cynthia Y Robinson, et al.
Journal of Patient-Reported Outcomes|October 31, 2021
Translation and cultural validation of the University of Washington Caregiver Stress and Benefit ScalesDagmar Amtmann, Alyssa M Bamer, Rana Salem, et al.
Journal of Opioid Management|November 5, 2015
Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrateCharles Argoff, Paul Arnstein, Steven Stanos, et al.
Journal of Clinical Pharmacology|March 18, 2003
Randomized, double-blind, placebo-controlled comparison of the analgesic efficacy of oxycodone 10 mg/acetaminophen 325 mg versus controlled-release oxycodone 20 mg in postsurgical painArnold R Gammaitoni, Bradley S Galer, Scott Bulloch, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapyValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
The Journal of Pain|September 1, 2006
Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning?Mark P Jensen, Robert H Dworkin, Arnold R Gammaitoni, et al.
The Journal of Pain|March 10, 2010
The assessment of pain quality: an item response theory analysisClare Waterman, Timothy W Victor, Mark P Jensen, et al.
Epilepsy & Behavior : E&B|February 8, 2018
Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver surveyJonathan D Campbell, Melanie D Whittington, Chong H Kim, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 29, 2002
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitorsAntonio Bonati, Paolo Lunghi, Loretta Gammaitoni, et al.
Pain Medicine (Malden, Mass.)|April 23, 2004
Palliative pharmaceutical care: a randomized, prospective study of telephone-based prescription and medication counseling services for treating chronic painA R Gammaitoni, R M Gallagher, M Welz, et al.
Pageof 23